The GLP-1 Wave Reaches Nursing Homes, Raising Questions About Cost and Care

GLP-1 medications are becoming increasingly common among nursing home residents, raising questions about treatment costs, insurance coverage and specialized care. At Venza Care, a New Jersey-based nursing home operator, approximately 30% to 40% of newly admitted residents are already taking GLP-1 medications, with even higher rates among short-stay patients. While these drugs may help manage diabetes, cardiovascular conditions and other chronic illnesses, providers must carefully monitor older adults for muscle loss, frailty and nutritional complications. Costs are another concern, with some Medicare beneficiaries facing a $50 monthly fee under a temporary coverage program and nursing homes potentially responsible for expensive medications under Medicare Part A.

As GLP-1 use expands among older adults, skilled nursing facilities, rehabilitation centers, long-term care providers, pharmacies, registered dietitian services, physical therapy practices and senior care organizations have a reason to highlight their expertise in managing complex health needs. Sellers can encourage these advertisers to emphasize individualized care, medication management, nutritional support and coordinated services that help patients and families navigate changing treatment needs.